Reuters: Health
Britain's healthcare cost agency on Tuesday recommended against including Johnson & Johnson's nasal spray for depression, Spravato, in the country's healthcare network, citing uncertainties over its clinical and cost effectiveness.
UK healthcare cost agency rejects J&J's nasal spray for depression
UK healthcare cost agency rejects J&J's nasal spray for depression
Reuters: Health
Britain's healthcare cost agency on Tuesday recommended against including Johnson & Johnson's nasal spray for depression, Spravato, in the country's healthcare network, citing uncertainties over its clinical and cost effectiveness.
Reuters: Health
Britain's healthcare cost agency on Tuesday recommended against including Johnson & Johnson's nasal spray for depression, Spravato, in the country's healthcare network, citing uncertainties over its clinical and cost effectiveness.
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment